2021
DOI: 10.1016/j.ifacol.2021.10.262
|View full text |Cite
|
Sign up to set email alerts
|

Optimal Scheduling of Therapy to Delay Cancer Drug Resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
2
1

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…From a practical standpoint, these formulas are a valuable tool to back-calculate the switching rates from experimentally measured fluctuations at a single time point of colony expansion. In the context of the cancer example, inferring the timescale of switching between drug-sensitive and drug-tolerant states is critical for the design of optimal drug treatment schedules [49]. Later on, we further generalize these results to multiple cell states with arbitrary switching topologies.…”
Section: Introductionmentioning
confidence: 94%
“…From a practical standpoint, these formulas are a valuable tool to back-calculate the switching rates from experimentally measured fluctuations at a single time point of colony expansion. In the context of the cancer example, inferring the timescale of switching between drug-sensitive and drug-tolerant states is critical for the design of optimal drug treatment schedules [49]. Later on, we further generalize these results to multiple cell states with arbitrary switching topologies.…”
Section: Introductionmentioning
confidence: 94%
“…Combining the colony-to-colony fluctuations in the number of surviving melanoma cells with the formula in Equation (5) revealed a drug-tolerant state with a transient heritability of roughly five to eight generations before melanoma cells switch back to being drug-sensitive (Saint-Antoine and Singh, 2022 ). From a therapeutic point of view, knowing these rates of switching can aid the design of drug therapy schedules to delay the emergence of cancer drug resistance (Paryad-Zanjani et al, 2021 ). These mathematical results also facilitated the development of a novel approach, Memory Sequencing (MemorySeq), that identifies all slowly fluctuating expression programs in rare cells (Shaffer et al, 2020 ).…”
Section: Inferring Transient Heritable Across Biology Systemsmentioning
confidence: 99%